Axonics, Inc.
NASDAQ:AXNX
Overview | Financials
Company Name | Axonics, Inc. |
Symbol | AXNX |
Currency | USD |
Price | 70.98 |
Market Cap | 3,627,731,016 |
Dividend Yield | 0% |
52-week-range | 70.98 - 70.98 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Mr. Raymond W. Cohen |
Website | https://www.axonics.com |
An error occurred while fetching data.
About Axonics, Inc.
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD